14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 4502.T
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Takeda Pharmaceutical Company Limited stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session.
(Updated on Jun 25, 2024)

Hold candidate since Jun 25, 2024 PDF

The Takeda Pharmaceutical Company Limited stock price gained 1.98% on the last trading day (Tuesday, 25th Jun 2024), rising from JP¥4,095.00 to JP¥4,176.00. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.43% from a day low at JP¥4,129.00 to a day high of JP¥4,188.00. The price has risen in 5 of the last 10 days but is still down by -1.02% for this period. Volume fell on the last day by -41 thousand shares and in total, 4 million shares were bought and sold for approximately JP¥16.48 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Takeda Pharmaceutical Company Limited stock with a 90% probability to be traded between JP¥3,981.81 and JP¥4,193.14 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

4502.T Signals & Forecast

The Takeda Pharmaceutical Company Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at JP¥4,079.43 and JP¥4,137.80. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 19, 2024, and so far it has risen 3.80%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Takeda Pharmaceutical Company Limited stock

Takeda Pharmaceutical Company Limited finds support from accumulated volume at JP¥4,173.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved JP¥59.00 between high and low, or 1.43%. For the last week the stock has had daily average volatility of 1.33%.

Our recommended stop-loss: JP¥3,971.57 (-4.90%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (4502.T) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect Takeda Pharmaceutical Company Limited to open at JP¥4,164.33, and during the day (based on 14 day Average True Range), to move between JP¥4,116.01 and JP¥4,235.99, which gives a possible trading interval of +/-JP¥59.99 (+/-1.44%) up or down from last closing price. If Takeda Pharmaceutical Company Limited takes out the full calculated possible swing range there will be an estimated 2.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at JP¥4,173.00 (0.07%) than the resistance at JP¥4,184.00 (0.19%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Takeda Pharmaceutical Company Limited stock A Buy?

Takeda Pharmaceutical Company Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.618 Hold/Accumulate Upgraded

Predicted Opening Price for Takeda Pharmaceutical Company Limited of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
JP¥4,164.33 ( 0.279%) JP¥4,176.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 4502.T

Fibonacci Support & Resistance Levels

Level Price
R3 4,223.33 1.13%
R2 4,200.80 0.594%
R1 4,186.87 0.260%
Price 4,176.00
S1 4,141.80 -0.82%
S2 4,127.87 -1.15%
S3 4,105.33 -1.69%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4,388.00 5.08%
R2 4,203.00 0.647%
R1 4,184.00 0.192%
Price 4,176.00
S1 4,173.00 -0.0718%
S2 4,129.00 -1.13%
S3 4,102.00 -1.77%

4502 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 27, 2024 Sep 27, 2024 Sep 27, 2024 JP¥0 0%
2 Mar 28, 2024 Mar 28, 2024 Jun 27, 2024 JP¥94.00 2.25%
3 Sep 28, 2023 Sep 28, 2023 Dec 01, 2023 JP¥94.00 2.25%
4 Mar 30, 2023 Mar 30, 2023 Mar 30, 2023 JP¥90.00 2.08%
5 Sep 29, 2022 Sep 29, 2022 Sep 29, 2022 JP¥90.00 2.38%

FAQ

What is the symbol for Takeda Pharmaceutical Company Limited Stock and on which exchange is it traded?
The symbol for Takeda Pharmaceutical Company Limited is 4502.T and it is traded on the TYO (Tokyo Stock Exchange).

Should I buy or sell Takeda Pharmaceutical Company Limited Stock?
Takeda Pharmaceutical Company Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Takeda Pharmaceutical Company Limited Stock?
Takeda Pharmaceutical Company Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Takeda Pharmaceutical Company Limited Stock.

What's the current price of Takeda Pharmaceutical Company Limited Stock?
As of the end of day on the Jun 25, 2024, the price of an Takeda Pharmaceutical Company Limited (4502.T) share was JP¥4,176.00.

What is the 52-week high and low for Takeda Pharmaceutical Company Limited Stock?
The 52-week high for Takeda Pharmaceutical Company Limited Stock is JP¥4,873.00 and the 52-week low is JP¥3,900.00.

What is the market capitalization of Takeda Pharmaceutical Company Limited Stock?
As of the Jun 25, 2024, the market capitalization of Takeda Pharmaceutical Company Limited is 6.425T.

When is the next earnings date for Takeda Pharmaceutical Company Limited?
The upcoming earnings date for Takeda Pharmaceutical Company Limited is Jul 31, 2024.
Click to get the best stock tips daily for free!

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Reves... 4502.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT